Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made a series of notable trades on Monday, December 1, according to ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) reported new trades for Monday, November 24, based on the latest daily ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

On Monday, Cathie Wood‘s Ark Invest executed significant trades, including notable purchases of ARK 21Shares Bitcoin ETF ...

CRISPR Therapeutics (CRSP) shares have seen considerable movement over the past month, leaving investors assessing what might be driving sentiment around this gene editing pioneer. With no recent ...

Congress Wealth Management LLC DE purchased a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target hoisted by Barclays from $55.00 to $56.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage currently ...